Dr. Thomas Ichim claims a peptide immunotherapy, SenoMune, targets cancer and aging
Ichim announces a peptide he calls the first cancer immunotherapy that also fights aging. The claim is his own and no study details are given.
Recap by typeshit. Post by Dr. Thomas Ichim on X.